Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Towards Eradication: Reducing Proviral HIV DNA With Interferon-a Immunotherapy

NCT02227277 is registered in ClinicalTrials.gov with The Wistar Institute as lead sponsor.

NCT NCT02227277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02227277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Towards Eradication: Reducing Proviral HIV DNA With Interferon-a Immunotherapy
Lead sponsor
The Wistar Institute
Phase
Phase 2
Overall status
Unknown status
Start date
February 11, 2015
Completion date
July 24, 2018
Enrollment
54 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, hiv/aids